Hacotano, Rocelyn .
HRN: 15-81-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2023
CEFUROXIME 500MG (TAB)
08/16/2023
08/23/2023
PO
500mg
BID
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes